{
    "id": "35b76d08-330b-b0a9-e063-6294a90a29e7",
    "indications": "mycophenolate mofetil indicated prophylaxis organ rejection , adult pediatric recipients 3 months age older allogeneic kidney [ ( 14.1 ) ] , heart [ ( 14.2 ) ] liver transplants [ ( 14.3 ) ] , combination immunosuppressants .",
    "contraindications": "adults kidney transplant 1 g twice daily , orally intravenously ( iv ) less 2 h ( 2.2 ) heart transplant 1.5 g twice daily orally iv , less 2 h ( 2.3 ) liver transplant 1.5 g twice daily orally 1 g twice daily iv , less 2h ( 2.4 ) pediatrics kidney transplant 600 mg/m 2 orally twice daily , maximum 2 g daily ( 2.2 ) heart transplant 600 mg/m 2 orally twice daily ( starting dose ) maximum 900 mg/m 2 twice daily ( 3 g 15 ml oral suspension ) ( 2.3 ) liver transplant 600 mg/m 2 orally twice daily ( starting dose ) maximum 900 mg/m 2 twice daily ( 3 g 15 ml oral suspension ) ( 2.4 ) mycophenolate mofetil injection alternative patients tolerate oral medication . administer within 24 hours following transplantation , patients tolerate oral medication , 14 days . ( 2.1 ) reduce interrupt dosing event neutropenia . ( 2.5 ) full prescribing information ( fpi ) : adjustments renal impairment neutropenia ( 2.5 ) , preparation iv solution . ( 2.6 )",
    "adverseReactions": "allergic mycophenolate mofetil observed ; therefore , mycophenolate mofetil injection contraindicated patients hypersensitivity mycophenolate mofetil ( mmf ) , mycophenolic acid ( mpa ) component product . mycophenolate mofetil contraindicated patients allergic polysorbate 80 ( tween ) .",
    "ingredients": [
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "MYCOPHENOLATE MOFETIL",
            "code": "9242ECW6R0"
        }
    ],
    "organization": "ONESOURCE SPECIALTY PHARMA LIMITED",
    "name": "mycophenolate mofetil",
    "effectiveTime": "20250522",
    "indications_original": "Mycophenolate mofetil is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney\n \n  [see\n  \n   Clinical Studies (14.1)],\n \n  heart\n \n  [see\n  \n   Clinical Studies (14.2)]\n \n  or liver transplants\n \n  [see\n  \n   Clinical Studies (14.3)]\n \n  , in combination with other immunosuppressants.",
    "contraindications_original": "ADULTS DOSAGE Kidney Transplant 1 g twice daily, orally or intravenously (IV) over no less than 2 h (2.2) Heart Transplant 1.5 g twice daily orally or IV, over no less than 2 h (2.3) Liver Transplant 1.5 g twice daily orally or 1 g twice daily IV, over no less than 2h (2.4) PEDIATRICS Kidney Transplant 600 mg/m 2 orally twice daily, up to maximum of 2 g daily (2.2) Heart Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m 2 twice daily (3 g or 15 mL of oral suspension) ( 2.3 ) Liver Transplant 600 mg/m 2 orally twice daily (starting dose) up to a maximum of 900 mg/m 2 twice daily (3 g or 15 mL of oral suspension) ( 2.4 ) Mycophenolate mofetil for injection is an alternative when patients cannot tolerate oral medication. Administer within 24 hours following transplantation, until patients can tolerate oral medication, up to 14 days. (2.1) Reduce or interrupt dosing in the event of neutropenia. (2.5) See full prescribing information (FPI) for: adjustments for renal impairment and neutropenia (2.5) , preparation of IV solution. (2.6)",
    "adverseReactions_original": "Allergic reactions to mycophenolate mofetil have been observed; therefore, mycophenolate mofetil for injection is contraindicated in patients with a hypersensitivity to mycophenolate mofetil (MMF), mycophenolic acid (MPA) or any component of the drug product. Mycophenolate mofetil is contraindicated in patients who are allergic to Polysorbate 80 (TWEEN)."
}